Proteinuria in Frasier Syndrome

Creative Commons License

Peco-Antic A., ÖZALTIN F., Parezanovic V., Milosevski-Lomic G., Zdravkovic V.

SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, cilt.141, ss.685-688, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 141
  • Basım Tarihi: 2013
  • Doi Numarası: 10.2298/sarh1310685p
  • Dergi Adı: SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.685-688
  • Anahtar Kelimeler: steroid resistant nephrotic syndrome, Wilms' tumour suppressor gene (WT1), angiotensin converting enzyme (ACE) inhibitor, angiotensin receptor blocker, indomethacin, FOCAL SEGMENTAL GLOMERULOSCLEROSIS, CONGENITAL NEPHROTIC SYNDROME, SPLICE-SITE MUTATION, WILMS-TUMOR-1 GENE, STEROID-RESISTANT, RENAL-FAILURE, WT1 MUTATIONS, INDOMETHACIN, NEPHROPATHY, PREVALENCE
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Introduction Frasier syndrome (FS) is a genetic form of glomerulopathy, which results from mutations in the Wilms' tumour suppressor gene (WT1). Proteinuria in FS has been traditionally considered unresponsive to any medication and FS inevitably progresses to end stage renal failure.